CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...